Inside Genome Editing With CBER's Dr. Peter Marks
Source: Cell & Gene
The FDA's Center for Biologics Evaluation and Research (CBER)'s Dr. Peter Marks makes his second appearance on Cell & Gene: The Podcast. This time Dr. Marks talks to Host, Erin Harris, about base editing and prime editing and their potential to meet unmet medical need. They discuss what clinical holds say about the FDA’s views on gene editing. They also discuss heritable genome editing.
Find Cell & Gene: The Podcast wherever you get your podcasts.
This website uses cookies to ensure you get the best experience on our website. Learn more